STE Forensic analysis
Price Targets (12m)
Detailed research
PART 1: TRADING EXECUTION
Trading Setup & Entry Strategy
STERIS (STE) is currently showing signs of a bearish trend with the price trading significantly below its 200-day SMA ($242.23). Given the recent analyst price target cuts following Q1 earnings, we are looking for a stabilization zone rather than an immediate reversal.
- >Entry Zone: $205.00 - $210.00. We want to see a base form near the Bollinger Band Lower ($204.11). Do not chase above $215.
- >Stop Loss: $199.50 (HARD). A breach below the psychological $200 level invalidates the recovery thesis.
- >Position Size: 2% of portfolio (Swing Trade).
- >Scaling Strategy: Start with 30% at $210.00. Add 40% if the price holds $205 support. Add remaining 30% only on a sustained move back above the 50-day SMA ($218.40).
- >Take Profit: Target $225.00 (Upper Bollinger Band) and $242.00 (200-day SMA).
- >Risk/Reward: ~1:2.5.
- >Max Hold Time: 2 weeks.
PART 2: DETAILED RESEARCH
Recent Material Events (8-K Analysis)
Recent filings indicate stability in corporate structure. The company is navigating the post-divestiture environment (Dental segment sold May 2024) and managing ongoing restructuring plans initiated in 2024 to enhance profitability and efficiency, which are largely nearing completion with minimal expected further impact on earnings.
Insider Trading Activity
Recent Form 4 filings show standard equity compensation activity. No significant open-market buying or selling by executives has been reported recently, suggesting neutral sentiment among leadership regarding near-term valuation.
Financial Health & Valuation
- >Revenue Quality: Strong recurring revenue mix (consumables/services).
- >Balance Sheet: $423.7M in cash vs $1.90B long-term debt. Debt-to-total capital ratio of 21.1% is conservative.
- >Reverse DCF: Implies a moderate long-term growth rate of roughly 6-8%, which is reasonable for a mature medical device player.
Technical Analysis & Trade Timing
- >Status: BEARISH_DOWNTREND. Price is below the 50-day and 200-day SMAs.
- >Indicators: RSI at 47.95 (Neutral). MACD is BULLISH, hinting at potential divergence, but the trend remains structurally broken until it reclaims the 50-day SMA.
- >Reconciliation: While fundamentals are solid (value territory), the technical trend is negative. Treat as a potential value play with strict technical stops.
Investment Recommendation
HOLD. The stock is currently in a "Value Trap" setup. While the valuation is becoming attractive, momentum is firmly negative. We recommend waiting for a higher-low formation before increasing exposure.
One-Liner Thesis: STERIS is a high-quality compounder currently working through a technical breakdown; accumulation is advised only upon confirmation of a support base near $205.